Similar articles

• Graft versus leukemia without fatal graft-versus-host disease in AKR mice.

  Chester SJ, Esparza AR, Albala MM. Chester SJ, et al. Cancer Res. 1975 Mar;35(3):637-9. Cancer Res. 1975. PMID: 234789
• Graft versus leukemia for "cell cure" of long-passage AKR leukemia after chemoradiotherapy.

  Saltzstein EC, Glasspiegel JS, Rimm AA, Giller RH, Bortin MM. Saltzstein EC, et al. Cancer Res. 1972 Aug;32(8):1658-62. Cancer Res. 1972. PMID: 4402951 No abstract available.
• Treatment of an established graft-versus-host reaction in AKR mice by adoptive immunotherapy.

  Chester SJ, Esparza AR, Albala MM. Chester SJ, et al. Cancer Res. 1975 Mar;35(3):634-6. Cancer Res. 1975. PMID: 234788
• Adoptive tumor immunotherapy in mice as an adjunct to whole-body x-irradiation and chemotherapy. A review.

  Fefer A. Fefer A. Isr J Med Sci. 1973 Mar;9(3):350-65. Isr J Med Sci. 1973. PMID: 4145461 Review. No abstract available.
• Immunotherapy of leukaemia.

  Malpas JS. Malpas JS. Schweiz Med Wochenschr. 1974 May 4;104(18):626-33. Schweiz Med Wochenschr. 1974. PMID: 4596725 Review. No abstract available.